Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nevro logo — We Believe True Innovation Transforms More Lives

Nevro

We Believe True Innovation Transforms More Lives

Founded 2006 United States Redwood City, United States 1216 employees Post-IPO Debt Total: $555.75M Biotechnology, Health Care +2

General Information

Company Name Nevro
Founded Year 2006
Location United States Redwood City, United States
Founders / Decision Makers
Team member Team member
Employees 1216
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Nevro. To contact Nevro, visit nevro.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Nevro

Nevro is a global medical device company with a mission to enhance the quality of life for patients enduring chronic pain. Founded in 2006, the company's focus on innovation has been evident in its HFX technology, which incorporates enduring technologies, optimized therapies, and individualized patient support. This comprehensive solution, known as HFX, includes the Senza spinal cord stimulation system as well as support services for chronic pain treatment, including painful diabetic neuropathy at a frequency of 10 kHz. The company's commitment to innovation is captured in their slogan: "We Believe True Innovation Transforms More Lives." Nevro's latest funding round saw a $200.00MPost-IPO Debt investment by Braidwell on 30 November 2023. Although headquartered in the United States, Nevro is making a global impact in the biotechnology, healthcare, manufacturing, and pharmaceutical industries.

Taxonomy: medical device, chronic pain, innovation, quality of life, HFX, Spinal cord stimulation, neuropathy treatment, patient support, global company

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $200.00M 1
Braidwell
Braidwell
30 Nov 2023
Post IPO Debt $172.50M -
15 Jun 2016
Debt Financing $50.00M 1
CRG
CRG
15 Dec 2014
Series C $48.00M 9
New Enterprise Associates MPM Capital Accuitive Medical Ventures
New Enterprise Associates, MPM Capital +7
07 Mar 2013
Series B $58.00M 7
Aberdare Ventures MPM Capital Accuitive Medical Ventures
Aberdare Ventures, MPM Capital +5
19 Jul 2011
Series A $21.75M 6
Aberdare Ventures MPM Capital Accuitive Medical Ventures
Aberdare Ventures, MPM Capital +4
10 Sep 2008
Seed Round $5.50M 6
Aberdare Ventures MPM Capital Bay City Capital
Aberdare Ventures, MPM Capital +4
04 Dec 2006

Nevro Alternatives & Competitors

View All Alternatives
Nevro vs
ONWARD Medical
ONWARD Medical The Netherlands

Empowering Movement

Post-IPO Debt
208 employees
Biotechnology, Health Care
Nevro vs
Fysius Rugexperts
Fysius Rugexperts The Netherlands

Het antwoord op nek- en rugpijn.

92 employees
Biotechnology, Health Care
Nevro vs
Neuvotion
Neuvotion United States

Restoring Independence

Seed
4 employees
Biotechnology, Health Care
Also compare with: Nevro vs Intracept by Boston Scientific Intracept by Boston Scientific View all alternatives

FAQ About Nevro

We Believe True Innovation Transforms More Lives
Nevro was founded in 2006.
Nevro is headquartered in Redwood City, United States.
Nevro operates in Biotechnology, Health Care, Manufacturing and Pharmaceutical. Its work centres on medical device, chronic pain, innovation and quality of life.
Nevro has approximately 1216 employees.
Nevro has completed 7 funding rounds, raising a total of $555.75M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Nevro include ONWARD Medical, Fysius Rugexperts, Neuvotion, Intracept by Boston Scientific, Vertos Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nevro and ONWARD Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nevro, https://bouncewatch.com/company/nevro, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes